Open an account

ProShares Nasdaq-100 Dynamic Buffer ETF

QB · ETF

$48.18−$0.1026 (−0.21%)TodayMarket closed ·
No price history for this range.

About QB

QB was created on 2025-06-26 by ProShares. The fund's investment portfolio concentrates primarily on downside hedge alternatives. The ETF currently has 3.94m in AUM and 102 holdings. QB tracks an index that invests in the Nasdaq-100 stocks while employing an options strategy designed to provide capped gains and buffer against the first 1% to 5% of Nasdaq-100s losses.

Issuer
ProShares
Tracks
Nasdaq-100 Dynamic Buffer Index - Benchmark TR Gross
Expense ratio
0.58%
Assets under management
$3.92M
Inception
Jun 26, 2025
Asset class
Alternatives
Website
proshares.com

QB key statistics

Price-earnings ratio
0.00
Average volume
982
Volume
84
Open price
$48.18
High today
$48.18
Low today
$48.18
52 Week high
$49.60
52 Week low
$41.78

ProShares Nasdaq-100 Dynamic Buffer ETF (QB) at a glance

ProShares Nasdaq-100 Dynamic Buffer ETF (QB) last traded at $48.18, with a price-to-earnings ratio of 0.00.

Volume so far is 84 shares, below the average of 982 shares a day.

Over the past year ProShares Nasdaq-100 Dynamic Buffer ETF has ranged from $41.78 to $49.60, and now sits 82% of the way up that range.

QB news

  • Press releaseBusiness Wire

    Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer

  • Press releaseBusiness Wire

    Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

  • Press releaseBusiness Wire

    Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

  • Press releaseBusiness Wire

    Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor

  • Press releaseBusiness Wire

    Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings

  • Press releaseBusiness Wire

    Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial

  • Press releaseBusiness Wire

    Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.

  • Chandrima Sanyal

    ProShares Launches ETFs That Reset Daily—So You Don't Have To Panic When Markets Are Choppy

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.